Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US Could Lose Its First Approver Advantage After FDA Layoffs

Apr 01 2025

• By Sarah Karlin-Smith, Elizabeth Orr, and Derrick Gingery

Dominoes falling in the dark — • Source: Shutterstock

Related Content

Pharma Looks To America First: US FDA Holds Overwhelming Lead Over EMA In Novel Approvals

Jul 05 2024

User Fee Deadline Concerns Emerge As US FDA Buyout Offer Sweetened With Paid Leave

Mar 11 2025

Germany: Two-Thirds Of Medtechs Rate EU Regulatory System Below FDA’s

Oct 24 2024

Updated: US FDA Commissioner Makary Was Sworn In, Knew Of Plan to Push Out Marks, Sources Say

Mar 31 2025

US FDA Staffing Uncertainty Could Impact Upcoming User Fee Negotiations

Mar 27 2025

Peter Marks Resigns From US FDA, Warns Kennedy Does Not Want Truth On Vaccines

Mar 29 2025

More from Medtech Insight

More from Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window